1Carollo DS,Nossaman BD,Ramadhyani U.Dexmedetomidine:a review of clinical applications[J].Curr Opin Anaesthesiol,2008,21(4):457-461.
2Welling EC,Donegan J.Neuroleptanalgesia using alfentanil for awake craniotomy[J].Anesth Analg,1989,68(1):57-60.
3Berkermtadt H,Perel A,Hadani M,et al.Monitored anesthesia care using remifentanil and propofol for awake craniotomy[J].Neurosurg Anesthesiol,2001,13(3):246-249.
4Christensen A.Update on dexmedetomidine for adult ICU sedation[J].Corm Med,2009,73(8):469-472.
5Kasuya Y,Govinda R,Rauch S,et al.The correlation between bispectral index and observational sedation scale in volunteers sedated with dexmedetomidine and propofol[J].Anesth Analg,2009,109(6):1811-1815.
6Kunisawa T,Nagata O,Nagashima M,et al.Dexmedetomidine suppresses the decrease in blood pressure during anesthetic induction and blunts the cardiovascular response to tracheal intubation[J].J CAin Anesth,2009,21(3):194-199.
7Grof TM,Bledsoe KA.Evaluating the use of dexmedetomidine in neurocritical care patients[J].Neurecrit Care,2010,12(3):356-361.
8limla T,Laitio R,Kentala E,et al.Highly variable pharmacokineties of dexmedetomidine during intensive care:a case report[J].J Med Case Reports,2010,25(4):73.
